Clinical Trial Update: Neoadjuvant Toripalimab Combined With Chemotherapy in the Treatment of Malignant Pleural Mesothelioma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating neoadjuvant toripalimab plus chemotherapy for malignant pleural mesothelioma is ongoing; status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Mesothelioma

Drugs mentioned

• Chemotherapy (chemotherapy)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Shanghai Pulmonary Hospital, Shanghai, China | Conditions: Malignant Pleural Mesothelioma | Phase 2 | Status: UNKNOWN